Premium Industrial News

COVID-19 Drives Demand for Active Pharmaceutical Ingredients (APIs) in North America

COVID-19 Drives Demand for Active Pharmaceutical Ingredients (APIs) in North America

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 153 Words
Attachment: API pharma 0421, PHARMA API

SUGAR LAND--April 29, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Pharmaceuticals and biological drugs are manufactured using ingredients usually produced offsite. Historically, the U.S. and Canada have relied heavily on countries such as China, India and Italy to supply these ingredients in a timely and economic manner. But the pandemic fueled a need to produce active pharmaceutical ingredients (APIs) domestically to secure supply chains for North American drug manufacturers.

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?